Type IA variation for application NMPA-2021-0064. Type IA variation: Formulation Change for Glucovantib — routine update

Variation Number
NMPA-2021-0064-V164
Type
Type IA
Application
Status
Completed
Fee
€1,552
Submitted
2022-10-27
Approved
—
Description

Type IA variation: Formulation Change for Glucovantib — routine update